NCT05960201View on ClinicalTrials.gov

Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in Invasive Lobular Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

August 10, 2023

Primary Completion Date

August 20, 2024

Study Completion Date

August 20, 2024

Conditions
Carcinoma, Lobular
Interventions
DRUG

[18F]fluoroestradiol (FES)

F-18 FES 111\~222 MBq(megabecquerel) injection

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER